Cerebral Vasomotor Reactivity in Parkinson's Disease: A Missing Link Between Dysautonomia, White Matter Lesions, and Cognitive Decline?-Reference-Cited by-同舟云学术

Cerebral Vasomotor Reactivity in Parkinson's Disease: A Missing Link Between Dysautonomia, White Matter Lesions, and Cognitive Decline?

Published:2020-10 Issue:8 Volume:7 Page:994-995
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Mov Disord Clin Pract

Author:

Castillo‐Torres Sergio A.¹^ORCID,Estrada‐Bellmann Ingrid¹²,Góngora‐Rivera Fernando¹³

Affiliation:

1. Neurology Department University Hospital Jose Eleuterio Gonzalez, Universidad Autonoma de Nuevo Leon Monterrey Mexico

2. Neurology Department, Parkinson and Movement Disorders Clinic University Hospital Jose Eleuterio Gonzalez, Universidad Autonoma de Nuevo Leon Monterrey Mexico

3. Stroke Unit, University Hospital Jose Eleuterio Gonzalez Universidad Autonoma de Nuevo Leon Monterrey Mexico

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mdc3.13074

Reference5 articles.

1. White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's Disease

2. Evaluation of cerebral vasomotor reactivity in Parkinson's disease: Is there any association with orthostatic hypotension?

3. Cerebral Vasoreactivity in Parkinson's disease: a cross‐sectional pilot study in a Hispanic cohort;Espino‐Ojeda A;J Alzheimers Dis Parkinsonism,2017

4. Levodopa does not change cerebral vasoreactivity in Parkinson's disease

5. Cerebral autoregulation and white matter lesions in Parkinson's disease and multiple system atrophy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between kidney function and Parkinson’s disease risk: a prospective study from the UK Biobank;BMC Public Health;2024-08-15

2. Reply To: Cerebral Vasomotor Reactivity in Parkinson's Disease: A Missing Link between Dysautonomia, White Matter Lesions, and Cognitive Decline?;Movement Disorders Clinical Practice;2020-10